Panuveitis
JH Choi, KJ Taubenslag - The Rose and Mackay Textbook of Autoimmune …, 2024 - Elsevier
Panuveitis refers to inflammation involving the anterior chamber, the vitreous, and the retina
and/or choroid, with no predominant site of inflammation. This chapter will discuss …
and/or choroid, with no predominant site of inflammation. This chapter will discuss …
[HTML][HTML] Effects of anti-TNF biologic drugs on uveitis severity in Behçet patients: systematic review and meta-analysis
S Abolhasani, A Khabbazi, F Hosseini… - International Journal …, 2022 - ncbi.nlm.nih.gov
AIM To investigate effects of anti-TNF biologic drugs on uveitis severity (comparing visual
acuity logMAR levels) in Behçet patients. METHODS Three databases PubMed, Scopus …
acuity logMAR levels) in Behçet patients. METHODS Three databases PubMed, Scopus …
[PDF][PDF] Adalimumab in the treatment of non-infectious uveitis
A Burek-Michalska, A Turno-Kręcicka - Adv Clin Exp Med, 2020 - dbc.wroc.pl
Non-infectious uveitis (NIU) is a serious sight-threatening condition whose pathogenesis is
often autoimmune in nature. It may manifest in any age group, though adults aged 20–50 …
often autoimmune in nature. It may manifest in any age group, though adults aged 20–50 …
Biologic therapy in large and small vessels vasculitis, and Behçet's disease: Evidence-and practice-based guidance
JA Correia, J Crespo, G Alves, F Salvador… - Autoimmunity …, 2023 - Elsevier
Objective Vasculitis are a very heterogenous group of systemic autoimmune diseases,
affecting large vessels (LVV), small vessels or presenting as a multisystemic variable vessel …
affecting large vessels (LVV), small vessels or presenting as a multisystemic variable vessel …
Biologic therapy for Behçet's uveitis: a systematic review
P Uke, R Gorodkin, N Beare - British Journal of Ophthalmology, 2020 - bjo.bmj.com
Background Biologics are increasingly used in management of Behçet's Disease (BD)
including ocular BD, but the evidence base is limited, mostly from studies of uveitis and BD …
including ocular BD, but the evidence base is limited, mostly from studies of uveitis and BD …
Safety of systemic treatments for Behçet's syndrome
ABSTRACT Introduction Treatment of Behçet's syndrome (BS) is aimed at controlling all
symptoms of such a complex disorder, ensuring a good quality of life and preventing life …
symptoms of such a complex disorder, ensuring a good quality of life and preventing life …
Is adalimumab safe and effective in patients with intestinal Behcet's disease in real-world practice?
Y Suzuki, T Hagiwara, M Kobayashi… - Intestinal …, 2021 - pesquisa.bvsalud.org
Background/Aims@# The safety and effectiveness of adalimumab was demonstrated in a
phase 3 trial in Japanese patients with intestinal Behçet's disease. The aim of this study was …
phase 3 trial in Japanese patients with intestinal Behçet's disease. The aim of this study was …
Adamantiades‐Behçet's disease therapy: current treatment options and recommendations with regard to the COVID‐19 pandemic
S Trevisini, G Trevisan, I Zalaudek… - Dermatologic …, 2022 - Wiley Online Library
Adamantiades‐Behçet's disease (ABD) is a chronic, idiopathic, relapsing immune‐mediate
disease that may involve multiple organs. It is characterized by recurrent oral and genital …
disease that may involve multiple organs. It is characterized by recurrent oral and genital …
Treatment of non-infectious retinal vasculitis
PA Rivera, A Gupta, N Kombo - Therapeutic Advances in …, 2023 - journals.sagepub.com
Retinal vasculitis (RV) refers to an entity in which the retinal vasculature is inflamed,
frequently with indications of inflammation elsewhere in the eye. Non-infectious RV can be …
frequently with indications of inflammation elsewhere in the eye. Non-infectious RV can be …
[HTML][HTML] Biologic treatments in Behçet's disease
F Alibaz-Öner, H Direskeneli - European journal of rheumatology, 2021 - ncbi.nlm.nih.gov
Behçet's disease (BD) significantly increases morbidity and mortality, especially in young
men. While vascular involvement is the most frequent cause of mortality, ocular involvement …
men. While vascular involvement is the most frequent cause of mortality, ocular involvement …